dilluns, 2 de febrer del 2015

Zimmer's $13B Biomet merger on track to close in Q1




Zimmer and Biomet are on track to close their $13 billion merger in the 1st quarter, Zimmer CEO David Dvorak said during a conference call discussing the orthopedic giant's 4th-quarter results.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1z6pIW8

Cap comentari:

Publica un comentari a l'entrada